Abstract：Objective: To investigate the risk factors of early rebleeding in patients with cirrhosis combined with esophagogastric varices after endoscopic treatment, and to provide accurate prediction for clinical endoscopic treatment of rebleeding.Methods: A total of 386 patients with cirrhosis combined with esophagogastric varices who were hospitalized in the Department of Gastroenterology in our hospital from March 2020 to March 2022 were selected for retrospective analysis, and 80 patients with early postoperative rebleeding were selected as the observation group. 306 patients who received endoscopic treatment without bleeding in hospital were selected as the control group. The clinical indicators of the two groups were compared. Results: Among 386 patients with cirrhosis combined with esophagogastric varices, 80 had early postoperative rebleeding, accounting for 20.73%, and 306 had no bleeding, accounting for 79.27%. Univariate analysis showed that Child -Pugh grade, albumin, serum sodium, spleen thickness, and whether the first band ligation was associated with patients with liver cirrhosis and esophageal varices, which were statistically significant (P<0.05); univariate analysis screened out statistically significant The difference indexes were analyzed by binary logistic regression, and the results showed that Child-Pugh grade, albumin, serum sodium, spleen thickness, and whether or not the first ligation was the independent risk factor for variceal rebleeding (P<0.05). Conclusion: Child-Pugh grade, albumin, serum sodium, spleen thickness, and whether or not the first ligation is an independent risk factor for variceal rebleeding can be used to predict the disease early, and it is worthy of clinical attention.
刘伟, 初晓燕, 刘森, 杜留锁, 娄兴旖. 肝硬化合并食管胃静脉曲张患者内镜下序贯治疗后早期再出血的危险因素分析[J]. 河北医学, 2024, 30(3): 469-473.
LIU Wei, CHU Xiaoyan, et al. Analysis of Risk Factors for Early Rebleeding after Endoscopic Sequential Treatment in Patients with Cirrhosis Combined with Esophagogastric Varices. HeBei Med, 2024, 30(3): 469-473.
[1] 张珈恺.食管静脉套扎联合生长抑素治疗肝硬化并发食管静脉曲张破裂出血的临床效果分析[D].吉林,延边大学,2020. [2] 张仕然,陈俊英,胡晓月,陈平.肝硬化伴食管静脉曲张破裂出血行脾切除加断流治疗与内镜治疗的疗效对比分析[J].腹部外科,2020,33(2):144-148. [3] Son X.Analysis of early rebleeding rate and related factors after esophageal varices in patients with liver cirrhosis[J].Acta Microscopica,2020,29(2):870-878. [4] Wu CK,Liang CM,Hsu CN,et al. The role of adjuvant acid suppression on the outcomes of bleeding esophageal varices after endoscopic variceal ligation[J]. Plos One,2017,12( 1):1-15. [5] 郑捷,潘志刚,苏东星.ESVD 用于门脉高压食管胃静脉曲张破裂出血治疗的临床效果研究[J].国际消化病杂志,2020,40(5):339-324. [6] 马佳丽,蒋煜,艾正琳,等.内镜下精准食管胃静脉曲张断流术患者预后及生存状况分析[J].现代消化及介入诊疗,2019,24(6):578-582. [7] 倪猛,张海洋. 内镜下套扎联合硬化剂注射治疗乙型肝炎肝硬化并发食管胃底静脉曲张破裂出血患者疗效及其再出血危险因素分析[J]. 实用肝脏病杂志,2018,21(2):241-244. [8] 郭芸蕾,鲁晓岚,程妍,等. 肝脾硬度联合门静脉宽度评估肝硬化食管 胃底静脉曲 张出血风 险[J]. 中华肝脏病杂志,2016,24(1):56-61. [9] 杨静.肝硬化患者食管胃静脉曲张破裂出血后门静脉血栓形成的微信啊因素分析[D].山西,山西医科大学,2021. [10] 高宇洁.内镜下套扎联合硬化剂序贯法治疗肝硬化食管静脉曲张疗效的Meta分析[D].黑龙江,吉林大学,2022.
2024, Vol. 30 
冀公网安备13080202000677号